repaglinide

American  

[ri-pag-luh-nahyd] / rɪˈpæg ləˌnaɪd /

noun

Pharmacology.

1. a benzoic acid derivative, C 27 H 36 N 2 O 4 , belonging to the meglitinide class of oral drugs used to treat type 2 diabetes.

---

Etymology

Origin of repaglinide

First recorded in 1980–85; abbreviation of re(lease) + pa(ncreas) + gli- (alteration of hypo gly cemia) + (megliti)nide ( def. )